Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis

Clinical trial NCT07282041 · RECRUITING

Trial details

NCT number: NCT07282041
Sponsor: National University of Singapore
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Intracranial Atherosclerosis Stroke, Ischemic

Start date: 2025-12-17
Primary completion: 2030-12-01
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.